Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,971.00
Ask: 1,972.00
Change: -29.00 (-1.45%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Lower Call As AstraZeneca Earnings Slip

Fri, 18th May 2018 07:42

LONDON (Alliance News) - Stock prices in London are seen opening marginally lower on Friday after the FTSE 100 set a record closing high on Thursday, as AstraZeneca reported a drop in earnings for the first quarter. IG futures indicate the FTSE 100 index is to open down 4.77 points at 7,783.20. The blue chip index closed up 0.7% at 7,787.97 on Thursday.In early corporate news, Anglo-Swedish drugmaker AstraZeneca said its performance in product sales benefited from strong launches and continued growth of newer medicines in China, but was hurt by lower sales of its cholesterol drug Crestor due to generic competition. For the quarter ending March 31, revenue was down 4.0% to USD5.18 billion from USD5.40 billion in the first quarter last year. Product sales rose 3% at actual exchange rates to USD4.98 billion, but the group added that product sales growth this year is weighted to the second half.Pretax profit declined 36% USD374 million against USD582 million. "AstraZeneca's pipeline continued to bring significant benefits for patients, most recently with the expanded US approval of Tagrisso for lung cancer and Lynparza for breast cancer. With our transformation coming into sharper commercial focus as the year progresses, we are confident of delivering on our goals," said Chief Executive Pascal Soriot. Jordan-founded generic drugmaker Hikma Pharmaceuticals said it has made an encouraging start to the year, with its Global Injectables unit performing well, The division was supported by six product launches in the year, and "strong quality track record enabling to meet increased demand across our marketed portfolio", the company added. "Our efforts to reduce costs across the group are on track and we continue to focus on enhancing and investing in our pipeline. Our cash position remains very healthy and our balance sheet is strong. Altogether, these factors reinforce our positive outlook for the Group and enable us to reiterate our guidance for the full year," said CEO Siggi Olafsson.Oil companies BP and ConocoPhillips are in discussions for an asset swap deal that would see the UK energy major gain a greater foothold in a key project in the North Sea and the US explorer get Alaskan assets, the Bloomberg reported citing people familiar with the matter.BP is considering taking Conoco's stake in the Clair field, in which BP already holds a 28.6% stake and is the operator, according to the financial news service. BP describes Clair as "the largest undeveloped hydrocarbon resource" in the UK.Elsewhere, Unite Group said Property Director Richard Simpson will leave the student accommodation developer to take the CEO role at student accommodation builder Watkin Jones. Simpson will remain with Unite until December and take up his new position at Watkin Jones in January. Ophir Energy said CEO Nick Cooper has stepped down effective immediately, Non-Executive Director Alan Booth will assume the role of interim CEO until a replacement is found. "This decision to appoint a new CEO reflects the company's ongoing move to rebalance its portfolio towards a larger production and cash flow base, to support more focused and sustainable exploration activity," Ophir said. Sterling was flat quoted at USD1.3516 early Friday, versus USD1.3510 at the London equities close on Thursday.In the economic events calendar on Friday there is eurozone trade data at 1000 BST.In the US on Thursday, Wall Street ended lower, with the Dow Jones Industrial Average closing down 0.2%, S&P 500 down 0.1% and Nasdaq Composite ending 0.2% lower.Stocks in the US closed lower on Thursday as traders expressed some uncertainty about the second round of trade talks between the US and China.Blaming the trade policies of previous administrations, US President Donald Trump expressed some doubt about whether the high-level trade talks with China will be successful.Trump told reporters he tends to doubt the talks will be successful in remarks during an Oval Office meeting with NATO Secretary General Jens Stoltenberg."The reason I doubt it is because China has become very spoiled," Trump said. "The EU has become very spoiled. Other countries have become very spoiled, because they always got 100% of whatever they wanted from the US."The Japanese Nikkei 225 index closed up 0.3% Friday. In China, the Shanghai Composite is up 0.8%, while the Hang Seng index in Hong Kong is up 0.5%.In Asian economic news, nationwide consumer prices in Japan were up just 0.6% on year in April, the Ministry of Internal Affairs and Communications said. That was shy of expectations for a gain of 0.7% and was down sharply from 1.1% in March.Core CPI was up 0.7% on year, beneath forecasts for 0.8% and down from 0.9% in the previous month. On a monthly basis, overall CPI was down 0.4% and core CPI eased 0.1%.
More News
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.